Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Markers released top-line results today after previously reporting the trial succeeded.
What happened?
Markers released top-line results today after previously reporting the trial succeeded.
Story details
Markers released top-line results today after previously reporting the trial succeeded.
Why it matters
This story helps build a stronger internal English tech archive around Technology, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.